Market revenue in 2020 | USD 295.5 million |
Market revenue in 2028 | USD 750.5 million |
Growth rate | 12.4% (CAGR from 2020 to 2028) |
Largest segment | Oral |
Fastest growing segment | Injectable |
Historical data covered | 2017 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Topical, Injectable, Oral |
Key market players worldwide | Pfizer Inc, Sanofi SA, AbbVie Inc, Galderma Group AG Registered Shares, Eli Lilly and Co, Regeneron Pharmaceuticals Inc, Otsuka Holdings Co Ltd, Novartis AG ADR, Incyte Corp, LEO Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to atopic dermatitis drugs market will help companies and investors design strategic landscapes.
Oral was the largest segment with a revenue share of 44.67% in 2020. Horizon Databook has segmented the Latin America atopic dermatitis drugs market based on topical, injectable, oral covering the revenue growth of each sub-segment from 2017 to 2028.
Latin America includes Brazil, Mexico, and Argentina. Technological developments are expected to contribute to market growth. In addition, increase in government spending, growing number of skilled healthcare professionals, focus of multinational pharmaceutical companies on development of advanced & novel therapeutics are likely to drive the atopic dermatitis drugs market in Latin America.
Low awareness about prevention & treatment of atopic dermatitis in undeveloped areas, high cost of treatment, and lack of favorable reimbursement policies are some of the key factors restraining market growth.
Latin America’s market is expected grow at a healthy rate, owing to government initiatives in the terms of regulations and treatment polices. Recently, Argentina proposed a reform to its healthcare system, stating that the controlling power of private payers should be with the government.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America atopic dermatitis drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America atopic dermatitis drugs market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account